US · Healthcare

Eisai Co. Ltd (ESALF)

Drug Manufacturers - Specialty & Generic

Eisai Co. Ltd (ESALF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ESALF

P/E ratio

18.00

Eisai Co. Ltd (ESALF) — FAQ

What is ESALF's P/E ratio?

The price-to-earnings (P/E) ratio for Eisai Co. Ltd (ESALF) is 18.00 (data as of 2026-03-24).

Does Eisai Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Eisai Co. Ltd (ESALF). Check the MyAverix Finance app for the latest dividend data.

What sector is Eisai Co. Ltd in?

Eisai Co. Ltd (ESALF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ESALF listed on?

ESALF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)